newsfilter
← Latest News
GlobeNewswire·

LexaGene Completes Analytical Studies for FDA EUA of COVID-19 Testing

BEVERLY, Mass., Oct. 25, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB:LXXGF, TSXV:LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing for veterinary